New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children’s vaccines, has brought immunisation rates to record highs in poor countries.
The WHO data, released today at the World Economic Forum’s annual meeting, project that since 2000, GAVI-funded immunisation programs in developing countries have prevented approximately 2.3 million future deaths, and that immunisations in 2006 alone prevented 600,000 future deaths.
Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, called the new data a highly encouraging sign of progress in global health. The Gates Foundation has committed a total of US$1.5 billion to support GAVI to date. GAVI has also received funding from 17 donor governments, including Germany, which recently committed €8 million (US$10.4 million).
"GAVI and its partners are leading a major turnaround in children’s health," said Melinda Gates. "When GAVI was founded, immunisation rates in poor countries were on the decline. Today, they are at an all-time high."
Since its inception in 2000, GAVI has committed US$2.6 billion to support national immunisation programs in more than 70 developing countries. According to the WHO projections released today, as a result of GAVI funding:
- 28 million more children have been protected against diphtheria, tetanus, and pertussis, helping to increase overall immunisation rates for these diseases from 63 percent in 1999 to 77 percent in 2006.
- 138 million more children have received new and under-used vaccines, such as those for hepatitis B, Hib, and yellow fever, helping to greatly increase immunisation coverage for these diseases. For example, the number of developing countries providing hepatitis B vaccine rose from 15 in 1999 to 61 in 2006.
"GAVI has demonstrated that with the right resources and leadership, it is possible to make dramatic health gains in poor countries," said Bill Gates. "We need to build on this success. No child should be denied access to lifesaving immunisations."
Despite GAVI’s progress, in 2005, an estimated 28 million children in developing countries were not immunised, and 2.5 million children died of vaccine-preventable diseases. To close this gap, WHO and UNICEF estimate that an additional US$10-15 billion will be needed for immunisation programs over the next decade. More funding will be needed to introduce vaccines that are currently in the development pipeline.
GAVI Commits US$500 Million to Strengthen Health Systems
In an effort to further increase global immunisation coverage, GAVI also announced today that it will invest US$500 million over five years to strengthen basic health systems in developing countries.
Weak health care infrastructure is often the main barrier to providing immunisations to children in developing countries, particularly in the poorest and most remote communities.
The new GAVI funding will provide flexible grants to developing countries for activities such as:
- Recruiting and training health care workers- Building and strengthening systems to distribute vaccines and drugs
"This is an exciting new direction for us," said Julian Lob-Levyt, Executive Secretary of GAVI. "Developing country leaders are telling us that in order for immunisation programs to be sustained, they need greater support for basic health infrastructure."
The first round of GAVI grants for strengthening health systems will be announced in February.
Jean-Pierre Le Calvez | EurekAlert!
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
24.05.2018 | Ecology, The Environment and Conservation
24.05.2018 | Medical Engineering
24.05.2018 | Physics and Astronomy